|Articles|December 15, 2001
Glaucoma Specialists Reflect on Advances
Developments over the past year have benefited ophthalmologists with an improved ability to diagnose and manage glaucoma, while ongoing research focusing on new therapeutic targets and innovative modalities is providing hope for even better treatment tools in the future.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















